Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
The Perth Blood Institute Limited
  • Perth Blood Institute
  • Thrombosis Australia
  • Thrombosis Australia Professionals
  • Search
  • Facebook
  • Linkedin
  • Email
  • Search
  • Facebook
  • Linkedin
  • Email
Subscribe Donate
Menu
  • Who we are
    • Vision, mission and values
    • What we do
    • Our facilities
    • Our team
      • Board
      • Key staff
      • Investigators
      • Patrons and ambassadors
      • Thrombosis Australia Advisory Panel
    • Work with us
  • Our clinical trials
    • Clinical trials
    • Collaborations
    • Participate in a clinical trial
  • Our research
    • Current research projects
    • Research highlights
    • Research collaborations
      • PBI
      • APTIN
    • Participate in a research project
  • Support and resources
    • For patients and families
    • Useful links
  • Our impact
    • Stories
  • Get involved
    • Donate
    • Appeals
    • Fundraise for us
    • Volunteer
    • Partner with us
    • Partners and Supporters
    • Make a bequest
    • User Feedback
  • News and events
    • News
    • Upcoming events
    • Past Events
    • Publications
  • Admin
    • Log in
  • Basket: (0 items)

Thrombosis Australia Advisory Panel

We have established an advisory panel to provide oversight and direction to Thrombosis Australia, to ensure that the information we provide is current and accurate. The panel consists of eminent healthcare professionals that collectively bring a wealth of experience and knowledge to the Thrombosis Australia Initiative. The breadth of their collective experience covers a range of clinical and academic interests relating to blood disorders, including distinguished editorial roles, clinical trial design and management, teaching, and extensive authorship.

The advisory panel sets the benchmark for the quality, accuracy, and currency of information by critically evaluating and reviewing content, and offers dynamic perspectives and advice to maintain oversight of the purpose and usefulness of the Thrombosis Australia Initiative in the fight against venous thromboembolism.

The panel is chaired by David Macey, member of the Perth Blood Institute's Board of Directors.                       


Dr Jennifer Curnow MBBS, FRACP, FRCPA, PhD

Dr Jennifer Curnow received her FRACP and FRCPA in Haematology in 2004/2005 and is the Director of Clinical Haematology for Western Sydney LHD at Westmead Hospital. Dr Curnow is a former president of the Thrombosis and Haemostasis Society of Australia (formerly the Australasian Society of Thrombosis and Haemostasis) and is chair of the THANZ Education subcommittee. Dr Curnow is also co-author of multiple national and state guidance documents for thrombosis and haemostasis. Dr Curnow chairs the NSW Clinical Excellence Commission Anticoagulant medicines working party.  


Prof Graeme J. Hankey MBBS MD FRCP FRCPEdin FRACP FAHA FESO FWSO FAAHMS

Graeme Hankey is Professor of Neurology at The University of Western Australia, and a Consultant Neurologist at Sir Charles Gairdner Hospital. He is an Associate Editor of Circulation, Editorial Consultant for The Lancet Neurology, a consulting Editor of the International Journal of Stroke, and Section co-Editor for the Epidemiology, Outcomes, & Population Science section of Stroke.  He is a Web of Science Highly Cited Researcher for 2017-2019, co-authoring 10 books and >900 research articles, with > 100,000 citations (h-index 121).


Professor Shirley Jansen PhD FRACS FRCS MBChB

Shirley Jansen is Professor of Vascular Surgery at Curtin University, and both Head of Department and Consultant Vascular and Endovascular Surgeon at Sir Charles Gairdner Hospital. She is Director of the Heart & Vascular Research Institute, Programme Lead Cardiovascular at Harry Perkins Institute for Medical Research and Adjunct Clinical Professor at the University of WA. Shirley has broad research interests in vascular and endovascular surgery with over 60 published research papers and 4 book chapters. She has extensive experience conducting clinical trials as primary investigator including first in man.


Emeritus Professor David Macey BSc (Hons) PhD (Chair)

A retired Professor of Animal Physiology, David is a contributing author to over 100 research papers, as well as multiple book chapters. Prior to his retirement, David held the positions of Director of Admissions at Murdoch University, Faculty Dean and Pro Vice Chancellor: Science and Engineering and Academic Chair for Medicine. He is currently Emeritus Professor at Murdoch and actively contributes to teaching and research at both Murdoch and Notre Dame Universities. David is a member of the PBI Board with responsibility for chairing the Advisory Panel.             


Dr Jamie Price FRACP FRCPA

Dr Jamie Price graduated from UWA in 1973. Dr Price was a resident at Princess Margaret and Royal Perth Hospital and specialises in haematology. Dr Price was appointed Clinical Haematologist at PMH and worked in haematology and oncology for over 30 years. His special interests are in paediatric haematology, bleeding disorders, and thrombotic disorders. One of his major objectives was in the prophylaxis of haemophilia and the preservation of joint function in haemophiliac patients.                     


Dr Peter Purnell MBBS FRACP FCSANZ

Dr Purnell is a cardiovascular imaging specialist based in Perth, WA. He was previously Head of Department of Cardiology at Joondalup Health Campus and currently works in research and private practice. His primary clinical interests are in heart failure, coronary disease, valvular heart disease, stroke prevention in atrial fibrillation, and cardio-oncology. He set up GenesisCare Cardio-Oncology service in WA in 2018 for medical oncology, expanded in 2019 to cover radiation oncology. Dr Purnell is the founding Director of Joondalup Cardiovascular Trials Inc., an independent, not-for-profit research organisation. He is also Head of Research GenesisCare Cardiology Western Australia.


Professor Huyen Tran MBBS (Hons) Master Clin Epi FRACP FRCPA

Professor Huyen Tran is a Professor at Australian Centre for Blood Diseases, Monash University, and Director of the Ronald Sawers Haemophilia Treatment Centre and Clinical Thrombosis Service, The Alfred Hospital. Both of these organisations undertake research based on their specialisation.  Prof Tran has over 75 publications in peer-reviewed journals, has been involved in clinical trials for 20 years and contributes to several advisory boards. He is Chair of the Australian Haemophilia Centre Director's Organisation, and Chair of the Clinical Trials Group of the Thrombosis and Haemostasis Society of Australia and New Zealand.


Published: 15th December, 2020

Author: Jake Harfield

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Please donate to Perth Blood Institute this Christmas

    Please donate to Perth Blood Institute this Christmas

    As Christmas draws near, we would like to take this opportunity to thank you for your continued support of the Perth Blood Institute (PBI). Your help is crucial in making a difference to the prevention, treatment, and cure of blood disorders. If you are able, please donate to our Christmas Appeal and help us to improve the quality of life of people living with blood disorders.

  • Thrombosis Australia Advisory Panel

    We have established an advisory panel to provide oversight and direction to Thrombosis Australia, to ensure that the information we provide is current and accurate.

  • Thrombosis Australia is now live!

    Thrombosis Australia is now live!

    Australians are set to benefit from a central resource ‘hub’ of authoritative information to increase awareness and understanding of deep vein thrombosis, pulmonary embolism and stroke, and improve their prevention, early detection and management.

  • Breakthrough for haemophilia A patients

    Breakthrough for haemophilia A patients

    Perth Blood Institute has participated in a ground-breaking clinical trial which has uncovered a new life-changing treatment for people with haemophilia.

Most read

  • Alicia's Story

    Alicia's Story

    Alicia was a very active and healthy 19-year-old when during a social game of netball, she rolled her ankle and was diagnosed with ligament damage. Learn more about Alicia's experience here.

  • Accessibility

  • COVID-19 and Thrombosis

    COVID-19 and Thrombosis

    The International Society of Thrombosis and Haemostasis has released information on COVID-19 and thrombosis. Here are the important facts; Having a blood clot does not increase your risk of acquiring COVID-19. Taking anticoagulants (blood-thinning medication) for a blood clot disorder also does not increase your risk of acquiring COVID-19.

  • Participate in a clinical trial

    Participate in a clinical trial

    PBI's Clinical Trials Unit actively runs numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers. We regularly take part in new clinical trials for improved treatments for blood disorders – this provides Western Australians with the opportunity to access new treatments.

  • Privacy Policy

    THE PERTH BLOOD INSTITUTE LIMITED ABN: 24164941815 (trading as Perth Blood Institute) takes your privacy seriously. We respect and uphold your right to privacy protection under the Australian Privacy Principles (APPs), by regulating the way in which we collect, use, disclose, hold and destroy your personal information. This Privacy Policy covers all personal information held by us.

  • Research Team Awarded DARF Dementia Grant

    Research Team Awarded DARF Dementia Grant

    Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk.

  • Bridget's Story

    Bridget's Story

    When Bridget was 35, at 25 weeks gestation during her third pregnancy, she was diagnosed suddenly with a pulmonary embolism (PE) in her lungs. Read Bridget's story here.

  • Clinical Research Fellowship

    The Perth Blood Institute (PBI) conducts medical research into blood disorders, including their causes, prevention and treatment options; facilitates access to high quality clinical trials for people affected by blood disorders; and provides information about blood disorders to patients and their families.

  • Elie's Story

    Elie's Story

    When Elie was a young, fit and healthy 22-year-old he noticed a lump in the side of his neck. He went to his GP complaining of fatigue, insomnia, and severe itching. After being misdiagnosed with glandular fever and then a mystery virus, he received a call from his doctor.

  • Investigating the effects of chronic Factor X anticoagulant exposure and dementia risk

    Investigating the effects of chronic Factor X anticoagulant exposure and dementia risk

    This project aims to examine FXa inhibition on the risk of cognitive decline and investigates the molecular mechanisms underlying this association.

Tag cloud

blood clots cancer chronic lymphocytic leukemia CLL contraceptive dementia haemophilia A leukemia Microangiopathic Thrombocytopenia multiple myeloma Non-Hodgkin Lymphoma pregnancy thrombosis Thrombotic Thrombocytopaenic Pupura Venous Thromboembolism VTE
Perth Blood Institute

Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists. Read more

Donate Fundraise

Published: 18th February, 2020

Updated: 4th May, 2020

Author:

Related topics:
  • Appeals

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Helpful links

  • Sitemap
  • Accessibility
  • Terms & conditions
  • Privacy policy
  • Contact us

Contact

18 Prowse Street
West Perth
WA 6005
P : +61 8 9200 5300
F : +61 8 9200 5324
E : [email protected]

  • Facebook
  • Instagram
  • Linkedin
  • Email

PBI is registered as an Income Tax Exempt Charity
CFN: CC21886
ACN: 164 941 815
ABN: 24 164 941 815

© Perth Blood Institute 2020